These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23344159)

  • 1. Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes.
    Grotz TE; Vaince F; Hieken TJ
    Melanoma Res; 2013 Apr; 23(2):132-7. PubMed ID: 23344159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
    Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
    J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of tumor infiltrating lymphocytes in melanoma.
    Burton AL; Roach BA; Mays MP; Chen AF; Ginter BA; Vierling AM; Scoggins CR; Martin RC; Stromberg AJ; Hagendoorn L; McMasters KM
    Am Surg; 2011 Feb; 77(2):188-92. PubMed ID: 21337878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.
    Sinnamon AJ; Sharon CE; Song Y; Neuwirth MG; Elder DE; Xu X; Chu EY; Ming ME; Fraker DL; Gimotty PA; Karakousis GC
    J Am Acad Dermatol; 2018 Aug; 79(2):245-251. PubMed ID: 29518458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
    Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
    Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.
    Mihm MC; Clemente CG; Cascinelli N
    Lab Invest; 1996 Jan; 74(1):43-7. PubMed ID: 8569196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level of TILs is an independent predictor of negative sentinel lymph node in women but not in men.
    Fortes C; Mastroeni S; Caggiati A; Passarelli F; Ricci F; Michelozzi P
    Arch Dermatol Res; 2021 Jan; 313(1):57-61. PubMed ID: 32266533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
    Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
    Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paucity of tumor-infiltrating lymphocytes is an unfavorable prognosticator and predicts lymph node metastases in cutaneous melanoma patients.
    Donizy P; Kaczorowski M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Anticancer Res; 2015 Jan; 35(1):351-8. PubMed ID: 25550571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
    Kruper LL; Spitz FR; Czerniecki BJ; Fraker DL; Blackwood-Chirchir A; Ming ME; Elder DE; Elenitsas R; Guerry D; Gimotty PA
    Cancer; 2006 Nov; 107(10):2436-45. PubMed ID: 17058288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of regression, its extent and tumor-infiltrating lymphocytes on sentinel node status, relapse, and survival in a 10-year retrospective study of melanoma patients.
    Maione V; Perantoni M; Bettolini L; Bighetti S; Arisi M; Tomasi C; Incardona P; Calzavara-Pinton P
    Melanoma Res; 2024 Aug; 34(4):343-349. PubMed ID: 38564432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.
    Kunte C; Geimer T; Baumert J; Konz B; Volkenandt M; Flaig M; Ruzicka T; Berking C; Schmid-Wendtner MH
    Melanoma Res; 2010 Aug; 20(4):330-7. PubMed ID: 20526218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating lymphocytes and their significance in melanoma prognosis.
    Schatton T; Scolyer RA; Thompson JF; Mihm MC
    Methods Mol Biol; 2014; 1102():287-324. PubMed ID: 24258985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients.
    Tas F; Erturk K
    Cancer Invest; 2017 Sep; 35(8):501-505. PubMed ID: 28799813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.